BAROnova Announces the Results of ENDObesity#0174 I Clinical Trial
4/22/2013 11:18:25 AM
More...
|
BAROnova Gets $27.3 Million for Weight Loss Device
2/15/2013 8:05:55 AM
More...
|
BAROnova Secures Series B Financing of $7.5M From Allergan Inc. (AGN); New Obesity Intervention Device Moving to New Clinical Trials Has the Potential to be Safer and More Cost Effective Without Surgery
10/23/2008 8:37:35 AM
More...
|